BBNX
Beta Bionics, Inc. Common StockNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$654.61M
P/E Ratio
—
EPS
$-1.37
Beta
—
52W High
$32.71
52W Low
$8.80
50-Day MA
$11.20
200-Day MA
$18.58
Dividend Yield
—
Profit Margin
-60.30%
Forward P/E
—
PEG Ratio
—
About Beta Bionics, Inc. Common Stock
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. The company is headquartered in Irvine, California.
Fundamentals
| Revenue (TTM) | $110.24M |
| Gross Profit (TTM) | $63.00M |
| EBITDA | $-75.45M |
| Operating Margin | -87.90% |
| Return on Equity | -22.70% |
| Return on Assets | -15.00% |
| Revenue/Share (TTM) | $2.51 |
| Book Value | $6.09 |
| Price-to-Book | 2.41 |
| Price-to-Sales (TTM) | 5.94 |
| EV/Revenue | 4.191 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 56.60% |
| Shares Outstanding | $44.56M |
| Float | $25.34M |
| % Insiders | 1.10% |
| % Institutions | 112.60% |
Historical Volatility
HV 10-Day
76.34%
HV 20-Day
68.30%
HV 30-Day
69.15%
HV 60-Day
81.66%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($19.18 target)
1
Strong Buy7
Buy3
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026